Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia1

Author： Roehrborn C.G.   McConnell J.D.   Lieber M.   Kaplan S.   Geller J.   Malek G.H.   Castellanos R.   Coffield S.   Saltzman B.   Resnick M.   Cook T.J.   Waldstreicher J.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.53, Iss.3, 1999-03, pp. : 473-480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia - relationship among symptoms, prostate volume and peak urinary flow rate

By Roehrborn C.G.   Boyle P.   Gould A.L.   Waldstreicher J.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 581-589

Elsevier

Access to resources Recommend Favorite

Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine

By Hedelin Hans   Johansson Niklas   Ströberg Peter  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 2, 2005-04 ,pp. : 154-159

Informa Healthcare

Access to resources Recommend Favorite

Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia

By Cadeddu J.A.   Pearson J.D.   Lee B.R.   Landis P.   Partin A.W.   Epstein J.I.   Carter H.B.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 795-800

Elsevier

Access to resources Recommend Favorite

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

By Andersen J.T.   Curtis Nickel J.   Marshall V.R.   Schulman C.C.   Boyle P.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 839-845

Elsevier

Access to resources Recommend Favorite

Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting

By Keetch D.W.   Andriole G.L.   Ratliff T.L.   Catalona W.J.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 901-905

Elsevier

Access to resources Recommend Favorite